SOS1 inhibitors
US12304915B2 · kind B2 · utility
0Cited by
5References
81Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 2022 |
| Grant date | May 20, 2025 |
| Priority date | — |
| Expiry date | Nov 29, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating cancer using compounds that inhibit Son of sevenless homolog 1 (SOS1) activity and pharmaceutical compositions containing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.